Neurovalens is delighted to be joining the Association of British HealthTech Industries (ABHI) at WHX Dubai 2026, the Middle East’s flagship healthcare and life sciences event, taking place from 9–12 February 2026 at Expo City Dubai.

Formerly known as Arab Health, WHX Dubai has evolved into a global health innovation summit — a bigger, broader and more internationally focused event bringing together over 4,000 visitors from 180 countries. Now hosted at the state-of-the-art Dubai Exhibition Centre, Expo City Dubai, the event provides an exceptional platform for companies to engage with healthcare leaders, distributors and investors from across the region and around the world.

This year, the ABHI UK Pavilion will showcase the breadth of UK life sciences expertise — from diagnostics and medical technology to pharma services, digital health, AI and genomics. The UK Pavilion represents the diversity and depth of the UK’s health innovation ecosystem, providing companies with a trusted platform to build connections and partnerships that drive real-world healthcare impact.

Among this year’s UK delegation is Neurovalens who will be exhibiting their non-invasive and drug-free products, designed to treat chronic insomnia (Modius Sleep) and Generalized Anxiety Disorder (Modius Calm).

Our Modius technology lays the foundation for products that are non-invasive, drug-free and can be used in the patients own home.

Dr. Jason McKeown, CEO (Neurovalens) said:

“We’re thrilled to be joining the ABHI UK Pavilion at WHX Dubai 2026 – a reimagined, rebranded and expanded evolution of Arab Health. This year’s event marks an exciting new chapter for global collaboration, and we look forward to showcasing our Modius products to partners and healthcare leaders from across the region.”

As the exclusive UK representative for Informa Markets’ healthcare portfolio, ABHI is proud to lead one of the largest national pavilions at the show, supported by Invest Northern Ireland, the Welsh Government, and the Department for Business and Trade (DBT). Together, these organisations will help strengthen the UK’s presence and promote international collaboration across the life sciences sector.

Michelle Michelucci, Head of International Events at ABHI, said:

“We’re so excited to be returning to Dubai for WHX 2026 with a strong delegation of UK innovators. The event has grown significantly in both size and influence, and it’s fantastic to see it reimagined at its new home in Expo City. From early-stage start-ups to global life sciences leaders, the UK Pavilion will once again highlight the best of British expertise on one of the world’s most influential stages. We can’t wait to welcome our companies to Dubai.”

The UK Pavilion remains a high-impact destination for visitors, offering a central location, strong branding, and tailored support from ABHI’s international team. Exhibitors will benefit from expert inmarket assistance, curated networking opportunities, and introductions to senior healthcare buyers and decision-makers.

Throughout the event, Neurovalens will be located at S7.D70F within the ABHI UK Pavilion.

To learn more about the ABHI UK Pavilion at WHX Dubai 2026, visit:

https://ukhealthcarepavilion.com/events/whx-dubai/